Metabolic Brain Disease

Aims & Scope

Metabolic Brain Disease serves as a forum for the publication of outstanding basic and clinical papers on all metabolic brain disease, including both human and animal studies.

The journal publishes papers on the fundamental pathogenesis of these disorders and on related experimental and clinical techniques and methodologies.

Metabolic Brain Disease is directed to physicians, neuroscientists, internists, psychiatrists, neurologists, pathologists, and others involved in the research and treatment of a broad range of metabolic brain disorders.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.5
2024	3.20

SJR (SCImago Journal Rank)

Year	Value
2024	0.941

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	83

Journal Rank

Year	Value
2024	5346

Journal Citation Indicator

Year	Value
2024	2572

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Neuroscience, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

  Citation: 755

  Authors: Michael, Raz, Jens, Stefan, Joe, Giulia, Marta, Petr, Bernard, Mario

• Maternal Separation in Rats Leads to Anxiety-Like Behavior and a Blunted ACTH Response and Altered Neurotransmitter Levels in Response to a Subsequent Stressor

  Citation: 267

  Authors: W. M. U., C. Y., M. E., D. J.

• Pathophysiology of Hepatic Encephalopathy: A New Look at Ammonia

  Citation: 265

  Authors: Roger F.

• GABA receptors in brain development, function, and injury

  Citation: 257

  Authors: Connie, Dandan

• Pathophysiology of Stroke: Lessons from Animal Models

  Citation: 245

  Authors: Philipp, Ulrich, Andreas

• Characteristics of Minimal Hepatic Encephalopathy

  Citation: 236

  Authors: Piero, Sara, Angelo, Marsha Y.

• Ammonia toxicity: from head to toe?

  Citation: 229

  Authors: Srinivasan, Rajeshwar P., Veronika, Vinita, Balasubramaniyan, Peter, Christopher F.

• Role of ammonia and inflammation in minimal hepatic encephalopathy

  Citation: 219

  Authors: D. L., G., S. W. M., R.

• Microglia

  Citation: 214

  Authors: Denise, Uwe-Karsten

• Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia

  Citation: 211

  Authors: Ghorbangol, Leila, Fariba, Mahdi, Alireza

---